EN DE

Bolak Company (002760) Fair Value & Analysis

Basic Materials · KR · Market cap 59.8B KRW

BC Bolak Company 002760 · KO
Price1,013 KRW
Fair Value664.00 KRW
Upside-34.5%
Quality74/100
Watch Bolak Company for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 5.5% net margin
Low debt · generates free cash flow
0.70% dividend yield
Mixed vs. peers (4/10)
Narrow moat 40/100
Evidence: High Range 498.00 KRW – 830.00 KRW Share as image

Fair value as of: Jul 22, 2026

From 23 valuation models · updated 19 days ago

Share price +6.2% over the past month.

A solid business, but screening 34% overvalued on our models.

What matters now

  • A high-quality business (quality 74/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (830.00 KRW). The favourable scenario is already priced in.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

2,632 KRW 837.00 KRW Fair Value 664.00 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range 837.00 KRW – 2,632 KRW · fair‑value band 498.00 KRW – 830.00 KRW · the 1,013 KRW price screens above the 664.00 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Bolak Company (002760) currently trades at 1,013 KRW, while our model-based Fair Value estimate is 664.00 KRW, implying the stock looks roughly 34.5% overvalued today. The Quality Score stands at 74/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Bolak Company generated revenue of 48.3B KRW at a net margin of 5.5%. Revenue declined 14.1% year over year. It earns a return on equity of 5.5%. Net debt stands at 1.3B KRW. Fundamentals as of Jul 22, 2026

Our scenario range runs from 498.00 KRW (bear case) to 830.00 KRW (bull case); at 1,013 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 34% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -34%, 002760 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 1,226 KRW 1,684 KRW 2,316 KRW 80
Residual Income 620.20 KRW 624.42 KRW 590.55 KRW 76
Rev-Margin DCF 719.75 KRW 935.86 KRW 1,178 KRW 74
All 23 models by family
DCF Models
FCF DCF 1,198 KRW 1,696 KRW 2,416 KRW 38
Owner Earnings 634.34 KRW 869.00 KRW 1,209 KRW 31
5Y Revenue Exit 719.75 KRW 918.43 KRW 1,153 KRW 39
5Y EBITDA Exit 792.60 KRW 1,049 KRW 1,330 KRW 41
5Y P/E Exit 795.67 KRW 1,055 KRW 1,311 KRW 38
10Y Revenue Exit 877.91 KRW 1,091 KRW 1,342 KRW 36
10Y EBITDA Exit 933.49 KRW 1,180 KRW 1,472 KRW 37
10Y P/E Exit 935.42 KRW 1,184 KRW 1,458 KRW 35
Earnings-Based
Graham-Dodd 265.60 KRW 666.81 KRW 865.66 KRW 54
PEG = 1.0 122.49 KRW 174.98 KRW 227.48 KRW 46
EPV 436.12 KRW 486.74 KRW 531.03 KRW 59
Multiples
P/E Multiple 498.00 KRW 664.00 KRW 830.00 KRW 63
P/S Multiple 498.00 KRW 664.00 KRW 830.00 KRW 58
P/B Multiple 498.00 KRW 664.00 KRW 830.00 KRW 55
EV/EBIT 523.33 KRW 653.64 KRW 783.95 KRW 53
EV/EBITDA 624.95 KRW 789.13 KRW 953.31 KRW 54
EV/Revenue 471.21 KRW 616.41 KRW 761.61 KRW 43
Asset-Based
NCAV (Graham) 406.77 KRW 545.07 KRW 813.53 KRW 50
Growth DCF
Growth DCF 1,226 KRW 1,684 KRW 2,316 KRW 80
Rev-Margin DCF 719.75 KRW 935.86 KRW 1,178 KRW 74
Economic Profit
Residual Income 620.20 KRW 624.42 KRW 590.55 KRW 76
ROIC Compounder 436.12 KRW 486.74 KRW 531.03 KRW 72
Growth Earnings
Growth-Adj P/E 391.26 KRW 558.94 KRW 726.63 KRW 68

Widest divergence: DCF Models (1,055 KRW) versus Earnings-Based (486.74 KRW). Highest evidence: Growth DCF (80).

Notify me when 002760 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 48.3B KRW
Revenue growth (YoY) -14.1%
Net margin 5.5%
Return on equity 5.5%
Free cash flow 5.9B KRW FY2025
Operating margin 5.0%
More key figures
Dividend yield 0.7%
EPS growth (YoY) +126%
Net debt 1.3B KRW FY2021

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 74/100

Of which business quality 73 · Market factors (momentum, volatility) 42

Profitability 36
Margins and returns on capital today
Quality Growth 76
Are margins and returns improving?
Cashflow 73
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 99
Disciplined investing over empire-building
Low Volatility 80
Calm price path (market factor)
Momentum 25
Price trend over the last 3–12 months (market factor)
52W Momentum 30
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally.

Full company description

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Na-CMC and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Bolak Company reported revenue of 50.1B KRW in FY2025 versus 39.8B KRW in FY2021, a compound +6.0%/yr. Reported net income was 2.3B KRW in FY2025, compounding +8.4%/yr from FY2021.

Growth Quality 70/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
50.1B KRW
Latest YoY
+5.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.5%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.2%
Revenue +6.0%/yr
FY21 39.8B KRW
FY22 48.4B KRW
FY23 46.8B KRW
FY24 47.6B KRW
FY25 50.1B KRW
Net income +8.4%/yr
FY21 1.7B KRW
FY22 3.1B KRW
FY23 858M KRW
FY24 −1.5B KRW
FY25 2.3B KRW

002760 screens 34% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Bolak Company Fair Value". https://www.fairvalue-calculator.com/stock/002760

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 74 · Top 25%
Fair Value upside −35% · Below median
Return on equity (TTM) 6% · Below median
Return on assets 3% · Below median
Net margin (TTM) 5% · Above median
Operating margin (TTM) 5% · Below median
Revenue growth -14% · Bottom 25%
Dividend yield (TTM) 0.7% · Below median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 19
PAST 22 · sector 23
HEALTH 100 · sector 95
DIVIDEND 14 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Bolak Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Bolak Company (002760) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of 664.00 KRW versus a price of 1,013 KRW, about −34% (overvalued).
What is the fair value of 002760?
Our model-based fair value for Bolak Company is 664.00 KRW (as of Jul 22, 2026), built from audited fundamentals. The current price is 1,013 KRW.
What is the quality score of 002760?
Bolak Company has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Bolak Company (002760)?
Bolak Company reported trailing-twelve-month revenue of about 48.3B KRW (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002760?
The net profit margin of Bolak Company is about 5.5%, meaning it keeps roughly 5.5% of revenue as net income. Based on the latest reported figures.
Does Bolak Company pay a dividend?
Bolak Company currently shows a dividend yield of about 0.77% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Bolak Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.